We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$39.3B
1-Year Est. Return
27.96%
This Fund
S&P 500
This Quarter
Est. Return
+13.03%
1 Year Est. Return
+27.96%
3 Year Est. Return
+58.37%
5 Year Est. Return
+80.22%
10 Year Est. Return
+439.89%
AUM
$39.3B
AUM Growth
+$3.7B
(+10%)
Cap. Flow
+$2.27B
Cap. Flow
% of AUM
5.78%
Top 10 Holdings %
Top 10 Hldgs %
11.24%
Holding
2,749
New
386
Increased
1,048
Reduced
996
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$393M |
| 2 |
AngloGold Ashanti
AU
|
+$356M |
| 3 |
General Dynamics
GD
|
+$348M |
| 4 |
NVIDIA
NVDA
|
+$202M |
| 5 |
Kroger
KR
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$441M |
| 2 |
CVS Health
CVS
|
+$424M |
| 3 |
United Parcel Service
UPS
|
+$359M |
| 4 |
Devon Energy
DVN
|
+$243M |
| 5 |
Target
TGT
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Miscellaneous | 16.91% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Champion Homes
SKY
$4.76B
| $26K | ﹤0.01% |
298
-44
| -13% | -$3.37K |
|
1302
AnaptysBio
ANAB
$1.68B
| $25K | ﹤0.01% |
+365
| New | +$22.1K |
|
1303
WIX.com
WIX
$3.19B
| $25K | ﹤0.01% |
551
+102
| +23% | +$6.31K |
|
1304
Capricor Therapeutics
CAPR
$547M
| $24K | ﹤0.01% |
+1,008
| New | +$30.6K |
|
1305
Monte Rosa Therapeutics
GLUE
$1.18B
| $24K | ﹤0.01% |
+981
| New | +$18.5K |
|
1306
Kontoor Brands
KTB
$4.02B
| $24K | ﹤0.01% |
289
-251,775
| -100% | -$18.4M |
|
1307
Stoke Therapeutics
STOK
$1.92B
| $24K | ﹤0.01% |
+731
| New | +$23.5K |
|
1308
Symbotic
SYM
$5.58B
| $24K | ﹤0.01% |
540
+297
| +122% | +$15.1K |
|
1309
Axcelis
ACLS
$3.55B
| $23K | ﹤0.01% |
121
+43
| +55% | +$6.38K |
|
1310
Vir Biotechnology
VIR
$1.93B
| $23K | ﹤0.01% |
+2,296
| New | +$21.8K |
|
|
PURR
1311
Hyperliquid Strategies Inc
PURR
$2.41B
| $23K | ﹤0.01% |
+2,938
| New | +$21.7K |
|
1312
Robert Half
RHI
$4.36B
| $22K | ﹤0.01% |
702
-468,013
| -100% | -$13.1M |
|
1313
Camtek
CAMT
$6.8B
| $21K | ﹤0.01% |
129
+58
| +82% | +$10.3K |
|
1314
Tyra Biosciences
TYRA
$1.71B
| $21K | ﹤0.01% |
+646
| New | +$21.4K |
|
1315
Cullinan Oncology
CGEM
$1.42B
| $20K | ﹤0.01% |
+1,104
| New | +$16.4K |
|
1316
Corvus Pharmaceuticals
CRVS
$1.21B
| $20K | ﹤0.01% |
+1,361
| New | +$18.9K |
|
1317
Cavco Industries
CVCO
$4.35B
| $20K | ﹤0.01% |
33
-5
| -13% | -$2.65K |
|
1318
Oceaneering
OII
$5.12B
| $19K | ﹤0.01% |
463
+209
| +82% | +$7.88K |
|
1319
Precigen
PGEN
$2.54B
| $19K | ﹤0.01% |
+3,289
| New | +$14.2K |
|
1320
Ardelyx
ARDX
$976M
| $18K | ﹤0.01% |
+3,443
| New | +$21K |
|
1321
California Resources
CRC
$4.82B
| $18K | ﹤0.01% |
334
-352,052
| -100% | -$21.7M |
|
|
CSW
1322
CSW Industrials
CSW
$5.03B
| $18K | ﹤0.01% |
65
-754
| -92% | -$209K |
|
1323
Inhibrx
INBX
$1.78B
| $18K | ﹤0.01% |
+186
| New | +$18.6K |
|
1324
Taysha Gene Therapies
TSHA
$1.82B
| $18K | ﹤0.01% |
+2,584
| New | +$15.3K |
|
1325
Annexon
ANNX
$923M
| $17K | ﹤0.01% |
+2,894
| New | +$16K |
|
Similar funds
PPF
CS
Pacer Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Pacer Advisors held 2,749 positions worth $39.3B, up 10% from $35.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Pacer Advisors deployed $2.27B of net new capital in Q2 2026, opening 386 new positions and adding to 1,048 existing holdings. Its largest new stake was AngloGold Ashanti: 3,744,168 shares worth $303M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was ConocoPhillips, an estimated $441M trimmed.
- Pacer Advisors's largest Q2 2026 buy was AngloGold Ashanti: 3,744,168 shares worth $303M.
- Pacer Advisors added most to Lowe's Companies in Q2 2026, an estimated $393M increase.
- Pacer Advisors's biggest Q2 2026 reduction was ConocoPhillips, cutting an estimated $441M.
- Pacer Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 11% of its $39.3B portfolio in Q2 2026.
- Pacer Advisors opened 386 new positions and closed 125 in Q2 2026.
- Pacer Advisors's portfolio value rose 10% quarter-over-quarter to $39.3B.
Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.